419 related articles for article (PubMed ID: 9862679)
1. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
Boackle SA; Morris MA; Holers VM; Karp DR
J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
[TBL] [Abstract][Full Text] [Related]
2. CD21 augments antigen presentation in immune individuals.
Boackle SA; Holers VM; Karp DR
Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
4. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
5. Complement receptors CD21 and CD35 in humoral immunity.
Roozendaal R; Carroll MC
Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
[TBL] [Abstract][Full Text] [Related]
6. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
[TBL] [Abstract][Full Text] [Related]
7. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.
Erdei A; Isaák A; Török K; Sándor N; Kremlitzka M; Prechl J; Bajtay Z
Mol Immunol; 2009 Sep; 46(14):2767-73. PubMed ID: 19559484
[TBL] [Abstract][Full Text] [Related]
8. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
[TBL] [Abstract][Full Text] [Related]
9. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
Grosjean I; Lachaux A; Bella C; Aubry JP; Bonnefoy JY; Kaiserlian D
Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
[TBL] [Abstract][Full Text] [Related]
10. CD21/CD35 in B cell activation.
Carroll MC
Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
[TBL] [Abstract][Full Text] [Related]
11. Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells.
Brown SL; Barrault DV; Phythian-Adams A; Knight AM
Int Immunol; 2006 Jan; 18(1):69-78. PubMed ID: 16291653
[TBL] [Abstract][Full Text] [Related]
12. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors.
Baiu DC; Prechl J; Tchorbanov A; Molina HD; Erdei A; Sulica A; Capel PJ; Hazenbos WL
J Immunol; 1999 Mar; 162(6):3125-30. PubMed ID: 10092761
[TBL] [Abstract][Full Text] [Related]
14. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
Arvieux J; Yssel H; Colomb MG
Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
[TBL] [Abstract][Full Text] [Related]
15. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A
Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438
[TBL] [Abstract][Full Text] [Related]
16. The processing and presentation of the self-antigen hemoglobin. Self-reactivity can be limited by antigen availability and costimulator expression.
Hagerty DT; Evavold BD; Allen PM
J Immunol; 1991 Nov; 147(10):3282-8. PubMed ID: 1834734
[TBL] [Abstract][Full Text] [Related]
17. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
18. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes.
Thornton BP; Vĕtvicka V; Ross GD
J Immunol; 1994 Feb; 152(4):1727-37. PubMed ID: 8120381
[TBL] [Abstract][Full Text] [Related]
19. Novel roles for murine complement receptors type 1 and 2 I. Regulation of B cell survival and proliferation by CR1/2.
Molnár E; Erdei A; Prechl J
Immunol Lett; 2008 Mar; 116(2):156-62. PubMed ID: 18243341
[TBL] [Abstract][Full Text] [Related]
20. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
Rickert RC
Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
